Healius (PGZ) Stock Overview
Provides medical laboratory and pathology services in Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
PGZ Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Healius Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.17 |
| 52 Week High | AU$0.61 |
| 52 Week Low | AU$0.17 |
| Beta | 0.27 |
| 1 Month Change | -40.97% |
| 3 Month Change | -51.98% |
| 1 Year Change | -61.01% |
| 3 Year Change | -91.28% |
| 5 Year Change | -93.66% |
| Change since IPO | -93.22% |
Recent News & Updates
Recent updates
Shareholder Returns
| PGZ | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -5.0% | 5.3% | -2.6% |
| 1Y | -61.0% | -15.5% | -1.4% |
Return vs Industry: PGZ underperformed the German Healthcare industry which returned -16.7% over the past year.
Return vs Market: PGZ underperformed the German Market which returned -0.8% over the past year.
Price Volatility
| PGZ volatility | |
|---|---|
| PGZ Average Weekly Movement | 11.6% |
| Healthcare Industry Average Movement | 6.7% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in DE Market | 13.2% |
| 10% least volatile stocks in DE Market | 2.7% |
Stable Share Price: PGZ's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: PGZ's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 5,962 | Paul Anderson | www.healius.com.au |
Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patient collection centers.
Healius Limited Fundamentals Summary
| PGZ fundamental statistics | |
|---|---|
| Market cap | €138.72m |
| Earnings (TTM) | -€333.08m |
| Revenue (TTM) | €830.88m |
Is PGZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PGZ income statement (TTM) | |
|---|---|
| Revenue | AU$1.37b |
| Cost of Revenue | AU$955.60m |
| Gross Profit | AU$414.40m |
| Other Expenses | AU$963.60m |
| Earnings | -AU$549.20m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
Aug 19, 2026
| Earnings per share (EPS) | -0.76 |
| Gross Margin | 30.25% |
| Net Profit Margin | -40.09% |
| Debt/Equity Ratio | 7.0% |
How did PGZ perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/10 06:47 |
| End of Day Share Price | 2026/06/10 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Healius Limited is covered by 19 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Saul Hadassin | Barrenjoey Markets Pty Limited |
| Benjamin Brayshaw | Barrenjoey Markets Pty Limited |
| Lyanne Harrison | BofA Global Research |